Exane Derivatives’s Healthcare Realty Trust Incorporated HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$82 Sell
3
-141
-98% -$3.94K ﹤0.01% 724
2022
Q1
$3.96K Hold
144
﹤0.01% 710
2021
Q4
$4.56K Buy
144
+97
+206% +$3.11K ﹤0.01% 625
2021
Q3
$1.4K Hold
47
﹤0.01% 828
2021
Q2
$1.43K Sell
47
-4,517
-99% -$141K ﹤0.01% 842
2021
Q1
$138K Buy
4,564
+4,198
+1,147% +$126K 0.04% 350
2020
Q4
$10.8K Sell
366
-7,220
-95% -$217K ﹤0.01% 522
2020
Q3
$228K Buy
+7,586
New +$218K 0.07% 202
2017
Q3
Sell
-1
Closed -$34 680
2017
Q2
$34 Hold
1
﹤0.01% 603
2017
Q1
$32 Hold
1
﹤0.01% 534
2016
Q4
$30 Hold
1
﹤0.01% 597
2016
Q3
$34 Hold
1
﹤0.01% 578
2016
Q2
$35 Hold
1
﹤0.01% 510
2016
Q1
$31 Buy
+1
New +$29 ﹤0.01% 564

Other funds holding HR

Exane Derivatives's HR Position: Q2 2022 in Review

Exane Derivatives reduced its Healthcare Realty Trust Incorporated (HR) stake by 98% in Q2 2022, selling an estimated $3.94K and leaving 3 shares worth $82. The position accounts for ﹤0.01% of the portfolio, ranked #724.

Exane Derivatives first reported a position in HR in Q1 2016 and has held it in 14 quarters since. The position peaked at $228K in Q3 2020. 276 funds tracked by Wall St. Rank hold HR as of Q2 2022.

  • Exane Derivatives held 3 shares of Healthcare Realty Trust Incorporated worth $82 as of Q2 2022.
  • Exane Derivatives sold 141 Healthcare Realty Trust Incorporated shares in Q2 2022, an estimated $3.94K.
  • Healthcare Realty Trust Incorporated made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #724 holding.
  • Exane Derivatives first reported a position in Healthcare Realty Trust Incorporated in Q1 2016 and has held it in 14 quarters since.
  • Exane Derivatives's Healthcare Realty Trust Incorporated position peaked at $228K in Q3 2020.
  • 276 funds tracked by Wall St. Rank held Healthcare Realty Trust Incorporated as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.